Clinical Trial Update: Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating point-of-care produced CAR T-cells versus commercial CAR T-cells in patients with relapsed/refractory large B-cell lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Commercial CAR T-cell(s)
• Point-of-care produced CAR T-cell

Snippet

Sponsor: University Medical Center Groningen | Conditions: NHL, DLBCL - Diffuse Large B Cell Lymphoma | Phase 2 | Status: RECRUITING